Paper33613554
An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.
Yan H and 7 others. Front Immunol, 2020. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer. Papers, record 33613554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33613554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Chemotherapy, Adjuvant | Major topic |
| Stomach Neoplasms | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| B-Lymphocytes | |
| CD4-Positive T-Lymphocytes | |
| CD8-Positive T-Lymphocytes | |
| Databases, Factual | |
| Databases, Genetic | |
| Disease-Free Survival | |
| Female | |
| Humans | |
| Kaplan-Meier Estimate | |
| Killer Cells, Natural | |
| Male | |
| Middle Aged | |
| Neoplasm Metastasis | |
| Neoplasm Staging | |
| Prognosis | |
| Proportional Hazards Models |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25894828 | Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. | Nat Med | 2015 | https://conductscience.org/library/papers/25894828 | PubMed |
| 2 | 17978289 | Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. | N Engl J Med | 2007 | https://conductscience.org/library/papers/17978289 | PubMed |
| 3 | 29620995 | Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/29620995 | PubMed |
| 4 | 30042208 | Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/30042208 | PubMed |
| 5 | 25079317 | Comprehensive molecular characterization of gastric adenocarcinoma. | Nature | 2014 | https://conductscience.org/library/papers/25079317 | PubMed |
| 6 | 21444866 | Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21444866 | PubMed |
| 7 | 32294529 | Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study. | Ann Oncol | 2020 | https://conductscience.org/library/papers/32294529 | PubMed |
| 8 | 11547741 | Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. | N Engl J Med | 2001 | https://conductscience.org/library/papers/11547741 | PubMed |
| 9 | 24138885 | Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. | Immunity | 2013 | https://conductscience.org/library/papers/24138885 | PubMed |
| 10 | 16822992 | Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16822992 | PubMed |
| 11 | 26075713 | Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer. | PLoS One | 2015 | https://conductscience.org/library/papers/26075713 | PubMed |
| 12 | 25638553 | Outcomes and endpoints in trials of cancer treatment: the past, present, and future. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/25638553 | PubMed |
| 13 | 28002059 | ImmunoScore Signature: A Prognostic and Predictive Tool in Gastric Cancer. | Ann Surg | 2018 | https://conductscience.org/library/papers/28002059 | PubMed |
| 14 | 8596936 | Enhancement of antitumor immunity by CTLA-4 blockade. | Science | 1996 | https://conductscience.org/library/papers/8596936 | PubMed |
| 15 | 28238215 | Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer. | J Clin Lab Anal | 2018 | https://conductscience.org/library/papers/28238215 | PubMed |
| 16 | 31615816 | Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer. | Cancer Immunol Res | 2019 | https://conductscience.org/library/papers/31615816 | PubMed |
| 17 | 32264809 | Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer. | Comb Chem High Throughput Screen | 2020 | https://conductscience.org/library/papers/32264809 | PubMed |
| 18 | 31315901 | Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients. | Clin Chem | 2019 | https://conductscience.org/library/papers/31315901 | PubMed |
| 19 | 32209727 | Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32209727 | PubMed |
| 20 | 20808728 | Regularization Paths for Generalized Linear Models via Coordinate Descent. | J Stat Softw | 2010 | https://conductscience.org/library/papers/20808728 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42183189 | Immunoscore and beyond: evolution and clinical integration of immune contexture-based biomarkers across solid tumours. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183189 | PubMed |
| 39802286 | Landscape of B lymphocytes and plasma cells in digestive tract carcinomas. | Ann Gastroenterol | 2025 | https://conductscience.org/library/papers/39802286 | PubMed |
| 38525439 | N6-methylation in the development, diagnosis, and treatment of gastric cancer. | J Transl Int Med | 2024 | https://conductscience.org/library/papers/38525439 | PubMed |
| 38077386 | The molecular mechanism of actions and clinical utilities of tumor infiltrating lymphocytes in gastrointestinal cancers: a comprehensive review and future prospects toward personalized medicine. | Front Immunol | 2023 | https://conductscience.org/library/papers/38077386 | PubMed |
| 36497422 | Gastric Cancer and the Immune System: The Key to Improving Outcomes? | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36497422 | PubMed |
| 35805132 | Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients. | Cells | 2022 | https://conductscience.org/library/papers/35805132 | PubMed |
| 35518357 | Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer. | Front Genet | 2022 | https://conductscience.org/library/papers/35518357 | PubMed |
| 34422960 | SMOX expression predicts the prognosis of non-small cell lung cancer. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/34422960 | PubMed |
| 34307129 | Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients. | Front Oncol | 2021 | https://conductscience.org/library/papers/34307129 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33613554
GET https://conductscience.org/api/papers/v1/33613554/references?page=2